UniProt ID | FXL19_HUMAN | |
---|---|---|
UniProt AC | Q6PCT2 | |
Protein Name | F-box/LRR-repeat protein 19 | |
Gene Name | FBXL19 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 694 | |
Subcellular Localization | ||
Protein Description | Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex.. | |
Protein Sequence | MGMKVPGKGESGPSALLTPPMSSSSRGPGAGARRRRTRCRRCRACVRTECGDCHFCRDMKKFGGPGRMKQSCLLRQCTAPVLPHTAVCLLCGEAGKEDTVEGEEEKFGLSLMECTICNEIVHPGCLKMGKAEGVINAEIPNCWECPRCTQEGRTSKDSGEGPGRRRADNGEEGASLGSGWKLTEEPPLPPPPPRRKGPLPAGPPPEDVPGPPKRKEREAGNEPPTPRKKVKGGRERHLKKVGGDACLLRGSDPGGPGLLPPRVLNPSQAFSSCHPGLPPENWEKPKPPLASAEGPAVPSPSPQREKLERFKRMCQLLERVPDTSSSSSDSDSDSDSSGTSLSEDEAPGEARNGRRPARGSSGEKENRGGRRAVRPGSGGPLLSWPLGPAPPPRPPQLERHVVRPPPRSPEPDTLPLAAGSDHPLPRAAWLRVFQHLGPRELCICMRVCRTWSRWCYDKRLWPRMDLSRRKSLTPPMLSGVVRRQPRALDLSWTGVSKKQLMWLLNRLQGLQELVLSGCSWLSVSALGSAPLPALRLLDLRWIEDVKDSQLRELLLPPPDTKPGQTESRGRLQGVAELRLAGLELTDASLRLLLRHAPQLSALDLSHCAHVGDPSVHLLTAPTSPLRETLVHLNLAGCHRLTDHCLPLFRRCPRLRRLDLRSCRQLSPEACARLAAAGPPGPFRCPEEKLLLKDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | KVPGKGESGPSALLT CCCCCCCCCCCCCCC | 65.75 | 21406692 | |
14 | Phosphorylation | GKGESGPSALLTPPM CCCCCCCCCCCCCCC | 34.77 | 21406692 | |
18 | Phosphorylation | SGPSALLTPPMSSSS CCCCCCCCCCCCCCC | 26.62 | 21406692 | |
22 | Phosphorylation | ALLTPPMSSSSRGPG CCCCCCCCCCCCCCC | 32.61 | 21406692 | |
23 | Phosphorylation | LLTPPMSSSSRGPGA CCCCCCCCCCCCCCC | 26.53 | 21406692 | |
23 | O-linked_Glycosylation | LLTPPMSSSSRGPGA CCCCCCCCCCCCCCC | 26.53 | 30379171 | |
24 | Phosphorylation | LTPPMSSSSRGPGAG CCCCCCCCCCCCCCC | 19.42 | 21406692 | |
25 | Phosphorylation | TPPMSSSSRGPGAGA CCCCCCCCCCCCCCH | 43.11 | 21406692 | |
48 | Phosphorylation | RCRACVRTECGDCHF CCCHHHCCCCCCCCH | 18.41 | 28555341 | |
99 | Phosphorylation | GEAGKEDTVEGEEEK CCCCCCCCCCCCHHH | 22.88 | 22985185 | |
115 | Phosphorylation | GLSLMECTICNEIVH CCCCEECCCCCCCCC | 18.43 | 22817900 | |
158 | O-linked_Glycosylation | EGRTSKDSGEGPGRR CCCCCCCCCCCCCCC | 42.34 | 30379171 | |
225 | Phosphorylation | EAGNEPPTPRKKVKG HCCCCCCCCCHHCCC | 46.57 | 29255136 | |
251 | Phosphorylation | DACLLRGSDPGGPGL CEEEECCCCCCCCCC | 33.91 | 23312004 | |
299 | Phosphorylation | AEGPAVPSPSPQREK CCCCCCCCCCHHHHH | 31.26 | 30576142 | |
301 | Phosphorylation | GPAVPSPSPQREKLE CCCCCCCCHHHHHHH | 37.69 | 30576142 | |
328 | Phosphorylation | PDTSSSSSDSDSDSD CCCCCCCCCCCCCCC | 42.98 | 30576142 | |
330 | Phosphorylation | TSSSSSDSDSDSDSS CCCCCCCCCCCCCCC | 40.75 | 30576142 | |
334 | Phosphorylation | SSDSDSDSDSSGTSL CCCCCCCCCCCCCCC | 43.26 | 30576142 | |
339 | Phosphorylation | SDSDSSGTSLSEDEA CCCCCCCCCCCCCCC | 28.57 | 30576142 | |
342 | Phosphorylation | DSSGTSLSEDEAPGE CCCCCCCCCCCCCCC | 42.65 | 30576142 | |
367 | Methylation | SSGEKENRGGRRAVR CCCCCCCCCCCCCCC | 50.46 | - | |
388 | Phosphorylation | LLSWPLGPAPPPRPP CCCCCCCCCCCCCCC | 49.64 | 18220336 | |
393 | Phosphorylation | LGPAPPPRPPQLERH CCCCCCCCCCCCCCC | 62.39 | 18220336 | |
408 | Phosphorylation | VVRPPPRSPEPDTLP CCCCCCCCCCCCCCC | 39.11 | 29255136 | |
413 | Phosphorylation | PRSPEPDTLPLAAGS CCCCCCCCCCCCCCC | 40.78 | 23927012 | |
420 | Phosphorylation | TLPLAAGSDHPLPRA CCCCCCCCCCCCCHH | 28.19 | 23927012 | |
470 | Ubiquitination | RMDLSRRKSLTPPML CCCHHHCCCCCHHHH | 49.02 | - | |
471 | Phosphorylation | MDLSRRKSLTPPMLS CCHHHCCCCCHHHHH | 35.35 | 22817900 | |
473 | Phosphorylation | LSRRKSLTPPMLSGV HHHCCCCCHHHHHHH | 32.22 | 21712546 | |
478 | Phosphorylation | SLTPPMLSGVVRRQP CCCHHHHHHHHHCCC | 24.24 | 22817900 | |
498 | Ubiquitination | SWTGVSKKQLMWLLN CCCCCCHHHHHHHHH | 40.95 | - | |
546 | Ubiquitination | LRWIEDVKDSQLREL CCCHHCCCHHHHHHH | 65.07 | - | |
546 | Sumoylation | LRWIEDVKDSQLREL CCCHHCCCHHHHHHH | 65.07 | - | |
560 | Phosphorylation | LLLPPPDTKPGQTES HHCCCCCCCCCCCCC | 44.93 | - | |
561 | Sumoylation | LLPPPDTKPGQTESR HCCCCCCCCCCCCCC | 55.31 | - | |
561 | Ubiquitination | LLPPPDTKPGQTESR HCCCCCCCCCCCCCC | 55.31 | - | |
565 | Phosphorylation | PDTKPGQTESRGRLQ CCCCCCCCCCCCCCC | 41.67 | - | |
567 | Phosphorylation | TKPGQTESRGRLQGV CCCCCCCCCCCCCHH | 43.34 | - | |
585 | Phosphorylation | RLAGLELTDASLRLL HHCCHHCCHHHHHHH | 21.83 | 23403867 | |
588 | Phosphorylation | GLELTDASLRLLLRH CHHCCHHHHHHHHHH | 19.48 | 23403867 | |
666 | Phosphorylation | LRSCRQLSPEACARL HHHHHHCCHHHHHHH | 16.62 | 28985074 | |
688 | Ubiquitination | PFRCPEEKLLLKDS- CCCCCHHHHCCCCC- | 42.65 | - | |
692 | Ubiquitination | PEEKLLLKDS----- CHHHHCCCCC----- | 56.76 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FXL19_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FXL19_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FXL19_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
COBA1_HUMAN | COL11A1 | physical | 22660580 | |
STRAA_HUMAN | STRADA | physical | 24035498 | |
WDR44_HUMAN | WDR44 | physical | 24035498 | |
RAC3_HUMAN | RAC3 | physical | 24684802 | |
MARF1_HUMAN | KIAA0430 | physical | 27173435 | |
SKP1_HUMAN | SKP1 | physical | 28614300 | |
BRE1A_HUMAN | RNF20 | physical | 28453857 | |
BRE1B_HUMAN | RNF40 | physical | 28453857 | |
CDK9_HUMAN | CDK9 | physical | 28453857 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-408, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-115, AND MASSSPECTROMETRY. |